AwardTape · Defense awards · Research and development · Health R&D · W81XWH22C0045
W81XWH22C0045: $0 definitive contract to Altrazeal Life Sciences Inc
Altrazeal Life Sciences Inc holds a definitive contract from Defense Health Agency with $0 obligated since Oct 2023 and $1.2M obligated over its life, against a ceiling of $1.2M. Latest action Jun 2, 2026.
Research and development for ARMY phase ii sbir month 1-24 project titled, developing an ideal first use agent to prevent sepsis in trauma wounds during care under fire
| PIID | W81XWH22C0045 |
|---|---|
| Type | definitive contract |
| Company | Altrazeal Life Sciences Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $0 |
| Total obligated (lifetime) | $1.2M |
| Ceiling (base and all options) | $1.2M |
| Base date | Sep 6, 2022 |
| Latest action | Jun 2, 2026 |
| End date | Jan 5, 2027 |
| Actions since Oct 2023 | 4 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Place of performance | TX |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial